BioSpace News Archive

Biotech Bay

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19

Fluidigm Corporation today confirmed that Omicron variant B.1.1.529, designated by the World Health Organization as a Variant of Concern, does not impact the capability of the Fluidigm® Advanta™ Dx SARS-CoV-2 RT-PCR Assay to detect the virus that causes COVID-19.

December 7, 2021
·
5 min read
Pharm Country

Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card

Scopus BioPharma Inc.(Nasdaq: “SCPS”) today mailed a letter to its stockholders in connection with the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) that will be reconvened on Monday, December 20, 2021 at 11:30 a.m., Eastern time.

December 7, 2021
·
12 min read
Biotech Bay

Iovance Biotherapeutics to Present at Upcoming Conferences - Dec 07, 2021

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, announced participation in the following conferences in December.

December 7, 2021
·
5 min read
FDA

Linus Biotechnology Inc. Receives FDA Breakthrough Device Designation forStrandDx™-ASD Exposome Sequencing Diagnostic

Linus Biotechnology Inc. today announced that the U.S. Food and Drug Administration Center for Devices and Radiological Health has granted the Company’s StrandDx™-ASD diagnostic aid the designation as a Breakthrough Device for Autism Spectrum Disorder (ASD).

December 7, 2021
·
5 min read
Pharm Country

Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from the 63rd American Society of Hematology (ASH) Annual Meeting

Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from the 63rd American Society of Hematology (ASH) Annual Meeting.

December 7, 2021
·
7 min read
Biotech Beach

Sorrento Therapeutics’ Clinical Laboratory Receives Accreditation From the College of American Pathologists

Sorrento Therapeutics, Inc. announced the Accreditation Committee of the College of American Pathologists has awarded accreditation to Sorrento’s Clinical Laboratory, located in San Diego, California, based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

December 7, 2021
·
5 min read
Drug Development

CP-COV03, a niclosamide-based oral antiviral drug, under study as possible cure for COVID-19 variants

CP-COV03 is a broad-spectrum antiviral drug candidate, developed by Hyundai Bioscience to treat COVID-19.

December 7, 2021
·
10 min read
Business

IMIDomics™ Announces Scientific and Business Advisory Boards

IMIDomics Inc., a global biotechnology company focused on the discovery and development of new medicines for the treatment of patients with immune-mediated inflammatory diseases, announced the formation and members of its Scientific Advisory Board and Business Advisory Board.

December 7, 2021
·
7 min read
Business

AbCellera Announces Changes to Its Board of Directors

AbCellera (Nasdaq: ABCL), today announced changes to its Board of Directors with the appointment of Andrew W. Lo, Ph.D., as an independent director and the resignation of John Hamer, Ph.D. Changes are effective immediately.

December 7, 2021
·
4 min read
BioMidwest

Deep Lens Announces Launch of Real Time Feasibility Offering to Assist in Oncology Clinical Trial Design and Site Selection

Deep Lens today announced the launch of its Real Time Feasibility offering, a new HIPAA-compliant tool designed to identify eligible patients and select the most effective sites in the Deep Lens Unity Network for oncology clinical trials in real-time.

December 7, 2021
·
4 min read